{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T03:58:42Z","timestamp":1785470322453,"version":"3.56.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-043618"],"award-info":[{"award-number":["INV-043618"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-024389"],"award-info":[{"award-number":["INV-024389"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Ethiopia has experienced a substantial resurgence in malaria in recent years, with increasing case numbers and a growing contribution of\n                    <jats:italic>Plasmodium vivax<\/jats:italic>\n                    in several regions. At the same time, new evidence supporting improved radical cure strategies, including high-dose primaquine and single-dose tafenoquine, alongside advances in molecular tools, offers opportunities to address persistent transmission and relapse. Against a backdrop of constrained funding and health system challenges, a stakeholder meeting was convened in Addis Ababa in November 2025 to review emerging evidence and discuss implications for malaria control and elimination in Ethiopia. The two-day meeting brought together 38 representatives from the National Malaria Control Programme, research institutions, regional health bureaus, and implementation partners. Key themes emerging from the meeting included: (i) systemic challenges shaping malaria control, including funding constraints, operational disruptions, and climate-related pressures; (ii) uncertainty around the contribution of relapse to overall\n                    <jats:italic>P. vivax<\/jats:italic>\n                    burden and the potential role of molecular tools to address this gap; (iii) important health system considerations for the introduction of G6PD-guided radical cure, particularly regarding service delivery levels and equity; (iv) the central role of economic evidence, with substantial uncertainty around drug pricing and implementation costs; and (v) the need for strengthened collaboration between researchers and policymakers to support evidence-informed decision-making. The meeting highlighted that, while more effective tools for\n                    <jats:italic>P. vivax<\/jats:italic>\n                    radical cure are available, their adoption in Ethiopia will depend on addressing key evidence gaps, particularly around relapse burden, feasibility, and cost-effectiveness. Given the current challenges, there is a pressing need for context specific research and continued dialogue between stakeholders, which will be critical to inform policy decisions and support progress towards malaria elimination.\n                  <\/jats:p>","DOI":"10.1186\/s12936-026-06050-4","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T03:10:35Z","timestamp":1785467435000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Building the toolkit to address malaria resurgence and radical cure of vivax malaria in Ethiopia: a meeting report"],"prefix":"10.1186","volume":"25","author":[{"given":"Tamiru Shibiru","family":"Degaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heven","family":"Sime","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shazia","family":"Ruybal-Pes\u00e1ntez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Osborne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthoni","family":"Mwaura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Alemu","family":"Bamboro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hellen","family":"Mnjala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getachew","family":"Mekonnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Ermias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneleye","family":"Fantahun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khor","family":"Puoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semira","family":"Abdelmenan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miraf","family":"Mesfin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohannes","family":"Hailemichael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endalamaw","family":"Gadisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmawi","family":"Hailu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyerusalem","family":"Beyene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damtie","family":"Lankir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gebregorgis","family":"Teklu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassen","family":"Mamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyob","family":"Amare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kebede","family":"Etana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonas","family":"Temesgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bisrat","family":"Nigusse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wondimagegn","family":"Adissu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asrat","family":"Hailu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delenasaw","family":"Yewhalaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asnakew","family":"Kebede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihad","family":"Abanegash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiwot","family":"Teka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sineshaw","family":"Legese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asefaw","family":"Getachew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashir","family":"Abdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mulgeta","family":"Minale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adugna","family":"Abera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geremew","family":"Tasew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketema","family":"Tafess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abay","family":"Sisay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negash","family":"Seyoum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dereje","family":"Dilu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdi","family":"Aliyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Devine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashenafi","family":"Assefa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Auburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamala","family":"Thriemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"6050_CR1","unstructured":"Organization WH: Disease Outbreak News; Malaria in Ethiopia. 2024."},{"key":"6050_CR2","unstructured":"WHO: World malaria report 2024. 2024."},{"key":"6050_CR3","unstructured":"WHO: World Malaria Report 2025. 2025."},{"key":"6050_CR4","unstructured":"Health FDRoEMo: Ethiopia National Malaria Strategic Plan 2021\u20132025. 2021."},{"key":"6050_CR5","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0140-6736(19)31285-1","volume":"394","author":"WRJ Taylor","year":"2019","unstructured":"Taylor WRJ, Thriemer K, von Seidlein L, Yuentrakul P, Assawariyathipat T, Assefa A, et al. Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial. Lancet. 2019;394:929\u201338.","journal-title":"Lancet"},{"key":"6050_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa1710775","volume":"380","author":"MVG Lacerda","year":"2019","unstructured":"Lacerda MVG, Llanos-Cuentas A, Krudsood S, Lon C, Saunders DL, Mohammed R, et al. Single-dose tafenoquine to prevent relapse of Plasmodium vivax malaria. N Engl J Med. 2019;380:215\u201328.","journal-title":"N Engl J Med"},{"key":"6050_CR7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJMoa1802537","volume":"380","author":"A Llanos-Cuentas","year":"2019","unstructured":"Llanos-Cuentas A, Lacerda MVG, Hien TT, Velez ID, Namaik-Larp C, Chu CS, et al. Tafenoquine versus primaquine to prevent relapse of Plasmodium vivax malaria. N Engl J Med. 2019;380:229\u201341.","journal-title":"N Engl J Med"},{"key":"6050_CR8","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S1473-3099(23)00430-9","volume":"24","author":"RJ Commons","year":"2024","unstructured":"Commons RJ, Rajasekhar M, Edler P, Abreha T, Awab GR, Baird JK, et al. Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis. Lancet Infect Dis. 2024;24:172\u201383.","journal-title":"Lancet Infect Dis"},{"key":"6050_CR9","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S1473-3099(23)00431-0","volume":"24","author":"M Rajasekhar","year":"2024","unstructured":"Rajasekhar M, Simpson JA, Ley B, Edler P, Chu CS, Abreha T, et al. Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis. Lancet Infect Dis. 2024;24:184\u201395.","journal-title":"Lancet Infect Dis"},{"key":"6050_CR10","unstructured":"WHO: WHO guidelines for malaria, 30 November 2024, V8.2. Geneva2024."},{"key":"6050_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-026-05968-z","author":"TS Degaga","year":"2026","unstructured":"Degaga TS, Thriemer K, Rajasekhar M, Abreha T, Assefa A, Douglas NM, et al. Analysis of the effect of primaquine dose on efficacy, safety, and tolerability in patients with Plasmodium vivax malaria in Ethiopia: a systematic review and individual patient data meta-analysis. Malar J. 2026 Jun 6. https:\/\/doi.org\/10.1186\/s12936-026-05968-z.","journal-title":"Malar J"},{"key":"6050_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(25)00729-7","author":"TS Degaga","year":"2026","unstructured":"Degaga TS, Pasaribu AP, Tripura R, Ghanchi N, Rajasekhar M, Adhikari B, et al. Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trial. Lancet Infect Dis. 2026. https:\/\/doi.org\/10.1016\/S1473-3099(25)00729-7.","journal-title":"Lancet Infect Dis"},{"key":"6050_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-025-05525-0","volume":"24","author":"SA Cassidy-Seyoum","year":"2025","unstructured":"Cassidy-Seyoum SA, Chheng K, Chanpheakdey P, Meershoek A, Hsiang MS, von Seidlein L, et al. Perceptions of shorter radical cure Plasmodium vivax treatment regimens and their implementation: a qualitative study among stakeholders in Cambodia. Malar J. 2025;24:304.","journal-title":"Malar J"},{"issue":"6","key":"6050_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2025-021763","volume":"11","author":"M Mwaura","year":"2026","unstructured":"Mwaura M, Engel N, Kejela M, Korra KG, Wodaj T, Shibiru Degaga T, et al. Risk perceptions of high-dose primaquine and tafenoquine among Plasmodium vivax malaria stakeholders in Ethiopia: a qualitative study. BMJ Glob Health. 2026;11(6): e021763. https:\/\/doi.org\/10.1136\/bmjgh-2025-021763.","journal-title":"BMJ Glob Health."},{"key":"6050_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-020-03330-5","volume":"19","author":"R Noviyanti","year":"2020","unstructured":"Noviyanti R, Miotto O, Barry A, Marfurt J, Siegel S, Thuy-Nhien N, et al. Implementing parasite genotyping into national surveillance frameworks: feedback from control programmes and researchers in the Asia-Pacific region. Malar J. 2020;19:271.","journal-title":"Malar J"},{"key":"6050_CR16","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.pt.2024.09.005","volume":"40","author":"N Dada","year":"2024","unstructured":"Dada N, Simpson VJ, Amenga-Etego LN, Oriero E, Miotto O, Torok ME, et al. Towards integrated malaria molecular surveillance in Africa. Trends Parasitol. 2024;40:964\u20139.","journal-title":"Trends Parasitol"},{"key":"6050_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-022-04352-2","volume":"5","author":"H Trimarsanto","year":"2022","unstructured":"Trimarsanto H, Amato R, Pearson RD, Sutanto E, Noviyanti R, Trianty L, et al. A molecular barcode and web-based data analysis tool to identify imported Plasmodium vivax malaria. Commun Biol. 2022;5:1411.","journal-title":"Commun Biol"},{"key":"6050_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1008576","volume":"16","author":"E Diez Benavente","year":"2020","unstructured":"Diez Benavente E, Campos M, Phelan J, Nolder D, Dombrowski JG, Marinho CRF, et al. A molecular barcode to inform the geographical origin and transmission dynamics of Plasmodium vivax malaria. PLoS Genet. 2020;16:e1008576.","journal-title":"PLoS Genet"},{"key":"6050_CR19","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.43510","author":"S Tessema","year":"2019","unstructured":"Tessema S, Wesolowski A, Chen A, Murphy M, Wilheim J, Mupiri AR, et al. Using parasite genetic and human mobility data to infer local and cross-border malaria connectivity in Southern Africa. Elife. 2019. https:\/\/doi.org\/10.7554\/eLife.43510.","journal-title":"Elife"},{"key":"6050_CR20","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.43481","author":"HH Chang","year":"2019","unstructured":"Chang HH, Wesolowski A, Sinha I, Jacob CG, Mahmud A, Uddin D, et al. Mapping imported malaria in Bangladesh using parasite genetic and human mobility data. Elife. 2019. https:\/\/doi.org\/10.7554\/eLife.43481.","journal-title":"Elife"},{"key":"6050_CR21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.pt.2015.12.001","volume":"32","author":"MJ Donnelly","year":"2016","unstructured":"Donnelly MJ, Isaacs AT, Weetman D. Identification, validation, and application of molecular diagnostics for insecticide resistance in malaria vectors. Trends Parasitol. 2016;32:197\u2013206.","journal-title":"Trends Parasitol"},{"key":"6050_CR22","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.62997","volume":"10","author":"CG Jacob","year":"2021","unstructured":"Jacob CG, Thuy-Nhien N, Mayxay M, Maude RJ, Quang HH, Hongvanthong B, et al. Genetic surveillance in the Greater Mekong subregion and South Asia to support malaria control and elimination. Elife. 2021;10:e62997.","journal-title":"Elife"},{"key":"6050_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2024.1478706","volume":"15","author":"JH Kattenberg","year":"2018","unstructured":"Kattenberg JH, Mutsaers M, Nguyen VH, Nguyen THN, Umugwaneza A, Lara-Escandell M, et al. Genetic surveillance shows spread of ACT resistance during period of malaria decline in Vietnam (2018-2020). Front Genet. 2018;15:1478706.","journal-title":"Front Genet"},{"key":"6050_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-024-05024-8","volume":"23","author":"YD Ndiaye","year":"2024","unstructured":"Ndiaye YD, Wong W, Thwing J, Schaffner SF, Brenneman KV, Tine A, et al. Two decades of molecular surveillance in Senegal reveal rapid changes in known drug resistance mutations over time. Malar J. 2024;23:205.","journal-title":"Malar J"},{"key":"6050_CR25","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12936-022-04226-2","volume":"21","author":"KB Beshir","year":"2022","unstructured":"Beshir KB, Parr JB, Cunningham J, Cheng Q, Rogier E. Screening strategies and laboratory assays to support Plasmodium falciparum histidine-rich protein deletion surveillance: where we are and what is needed. Malar J. 2022;21:201.","journal-title":"Malar J"},{"key":"6050_CR26","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/S1473-3099(22)00697-1","volume":"23","author":"V Wasakul","year":"2023","unstructured":"Wasakul V, Disratthakit A, Mayxay M, Chindavongsa K, Sengsavath V, Thuy-Nhien N, et al. Malaria outbreak in Laos driven by a selective sweep for Plasmodium falciparum kelch13 R539T mutants: a genetic epidemiology analysis. Lancet Infect Dis. 2023;23:568\u201377.","journal-title":"Lancet Infect Dis"},{"key":"6050_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fitd.2023.1085862","author":"S Ruybal-Pesantez","year":"2023","unstructured":"Ruybal-Pesantez S, Saenz FE, Deed SL, Johnson EK, Larremore DB, Vera-Arias CA, et al. Molecular epidemiology of continued Plasmodium falciparum disease transmission after an outbreak in Ecuador. Front Trop Dis. 2023. https:\/\/doi.org\/10.3389\/fitd.2023.1085862.","journal-title":"Front Trop Dis"},{"key":"6050_CR28","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S1473-3099(18)30068-9","volume":"18","author":"R Amato","year":"2018","unstructured":"Amato R, Pearson RD, Almagro-Garcia J, Amaratunga C, Lim P, Suon S, et al. Origins of the current outbreak of multidrug-resistant malaria in southeast Asia: a retrospective genetic study. Lancet Infect Dis. 2018;18:337\u201345.","journal-title":"Lancet Infect Dis"},{"key":"6050_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13412-x","volume":"10","author":"AR Taylor","year":"2019","unstructured":"Taylor AR, Watson JA, Chu CS, Puaprasert K, Duanguppama J, Day NPJ, et al. Resolving the cause of recurrent Plasmodium vivax malaria probabilistically. Nat Commun. 2019;10:5595.","journal-title":"Nat Commun"},{"key":"6050_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-62357-x","volume":"16","author":"M Kleinecke","year":"2025","unstructured":"Kleinecke M, Sutanto E, Rumaseb A, Hoon KS, Trimarsanto H, Osborne A, et al. Microhaplotype deep sequencing assays to capture Plasmodium vivax infection lineages. Nat Commun. 2025;16:7192.","journal-title":"Nat Commun"},{"key":"6050_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002299","volume":"14","author":"T Abreha","year":"2017","unstructured":"Abreha T, Hwang J, Thriemer K, Tadesse Y, Girma S, Melaku Z, et al. Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: a randomized controlled trial. PLoS Med. 2017;14:e1002299.","journal-title":"PLoS Med"},{"key":"6050_CR32","doi-asserted-by":"crossref","unstructured":"Rosado J, Han J, Obadia T, Munro J, Traore Z, Schoffer K, Brewster J, Bourke C, Vinetz JM, White M, et al. Understanding Plasmodium vivax recurrent infections using an amplicon deep sequencing assay, PvAmpSeq, identity-by-descent and model-based classification. medRxiv 2025.","DOI":"10.1101\/2025.05.26.25327775"},{"key":"6050_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/puh2.70099","volume":"4","author":"K Ayele","year":"2025","unstructured":"Ayele K. Impacts of armed conflicts on healthcare and nutrition services in Ethiopia: a narrative review. Public Health Chall. 2025;4:e70099.","journal-title":"Public Health Chall"},{"key":"6050_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-025-13084-y","volume":"25","author":"A Atnafu","year":"2020","unstructured":"Atnafu A, Teshale G, Dellie E, Park YS. Exploring health system challenges and gaps for crisis response in Ethiopia: a scoping review of publications and reports from 2020-2024. BMC Health Serv Res. 2020;25:928.","journal-title":"BMC Health Serv Res"},{"key":"6050_CR35","unstructured":"New partnership launched to accelerate elimination of relapsing P. vivax malaria that poses a risk to an estimated 2.5 billion people worldwide. https:\/\/www.path.org\/media-center\/new-partnership-launched-accelerate-elimination-relapsing-p-vivax-malaria-poses-risk-estimated-25-billion-people-worldwide\/"},{"key":"6050_CR36","unstructured":"Methods for surveillance of antimalarial drug efficacy. http:\/\/whqlibdoc.who.int\/publications\/2009\/9789241597531_eng.pdf"},{"key":"6050_CR37","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.pt.2023.08.007","volume":"39","author":"A Mayor","year":"2023","unstructured":"Mayor A, Ishengoma DS, Proctor JL, Verity R. Sampling for malaria molecular surveillance. Trends Parasitol. 2023;39:954\u201368.","journal-title":"Trends Parasitol"},{"key":"6050_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003560","volume":"18","author":"S Auburn","year":"2021","unstructured":"Auburn S, Cheng Q, Marfurt J, Price RN. The changing epidemiology of Plasmodium vivax: insights from conventional and novel surveillance tools. PLoS Med. 2021;18:e1003560.","journal-title":"PLoS Med"},{"key":"6050_CR39","doi-asserted-by":"crossref","unstructured":"Rai A, Sutanto E, Ghimire P, Wangchuk S, Drukpa T, Alam MS, Ghanchi N, Rahim AG, Rumaseb A, Trimarsanto H, et al. Genetic evidence of cross-border Plasmodium vivax spread in a malaria pre-elimination region of South Asia. J Infect Dis 2026.","DOI":"10.64898\/2026.02.02.26345415"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-026-06050-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-026-06050-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-026-06050-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T03:10:40Z","timestamp":1785467440000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12936-026-06050-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6050"],"URL":"https:\/\/doi.org\/10.1186\/s12936-026-06050-4","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"assertion":[{"value":"22 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AK, AG, BN, KE, GM, DY and DD are members of the national technical working group. AD participated in the World Health Organization Guideline Development Group on near-patient G6PD tests to support safe and effective\n                      P. vivax\n                      anti-relapse treatment.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"278"}}